After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

In the second quarter of 2025, Michael Burry’s Scion Asset Management added five new stocks to its portfolio while trimming ...

U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

Regeneron Pharmaceuticals, Inc. saw a notable boost in its financial performance this quarter. The Public Sector Pension ...

Voters in Detroit and seven other communities across southeast Michigan are voting on candidates for mayor and other municipal offices.